Cover Image
市場調查報告書

IVD(體外診斷)實施數、價格分析

IVD Procedure Volumes and Pricing Analysis

出版商 Kalorama Information 商品編碼 261348
出版日期 內容資訊 英文 213 Pages
訂單完成後即時交付
價格
Back to Top
IVD(體外診斷)實施數、價格分析 IVD Procedure Volumes and Pricing Analysis
出版日期: 2015年01月14日 內容資訊: 英文 213 Pages
簡介

本報告提供全球IVD及臨床檢驗的實施數的相關調查,各類別的全球實施數估計、實際成果與預測,主要產品、系統設備的價格估計,主要市場區隔,各種基本的銷售額預測等。

第1章 摘要整理

第2章 簡介

第3章 照護現場(POC)檢驗的實施數

  • 概要
  • 檢驗的種類
    • OTC檢驗
    • 血糖值檢驗
    • 妊娠/排卵檢驗
    • 專門檢驗
    • 感染疾病疾病檢驗
    • 重症加護檢驗
    • 其他
  • 主要產品、價格
  • 全球銷售額:各檢驗類型
  • 全球實施數:各檢驗類型
  • 價格趨勢
  • 實施數趨勢
  • 第4章 核心實驗室檢驗的治療數
  • 概要
  • 實驗的種類
    • 臨床化學
    • 一般化學
    • 血氣分析
    • 尿液檢查
    • 免疫檢測
    • 感染疾病疾病
    • 心臟標記
    • 腫瘤標記(癌症篩檢)
    • 糖尿病
    • 自體免疫疾病
    • 其他
  • 主要產品、價格
  • 全球銷售額:各檢驗類型
  • 全球實施數:各檢驗類型
  • 價格趨勢
  • 實施數趨勢

第5章 分子檢驗實施數

  • 概要
  • 實驗的種類
    • 感染疾病
    • 癌症
    • 遺傳病
    • 其他
  • 主要產品、價格
  • 全球銷售額:各檢驗類型
  • 全球實施數:各檢驗類型
  • 價格趨勢
  • 實施數趨勢

第6章 血液檢驗的實施數

  • 概要
  • 實驗的種類
  • 主要產品、價格
  • 全球銷售額
  • 全球實施數
  • 價格趨勢
  • 實施數趨勢

第7章 血液凝固檢驗的實施數

  • 概要
  • 實驗的種類
    • 凝血酵素原時間檢驗(PT)
    • 活躍凝血酵素原時間(PTT)
  • 主要產品、價格
  • 全球銷售額:各檢驗類型
  • 全球實施數:各檢驗類型
  • 價格趨勢
  • 實施數趨勢

第8章 微生物檢驗的實施數

  • 概要
  • 實驗的種類
  • 主要產品、價格
  • 全球銷售額:各檢驗類型
  • 全球實施數:各檢驗類型
  • 價格趨勢
  • 實施數趨勢

第9章 血液貯存檢驗的實施數

  • 概要
  • 實驗的種類
    • 自動操作面板/試劑
    • 手動操作面板/試劑
    • 血液培養
    • 色素生成媒體
  • 主要產品、價格
  • 全球銷售額
  • 全球實施數
  • 價格趨勢
  • 實施數趨勢

第10章 組織、細胞檢驗的實施數

  • 概要
  • 實驗的種類
    • Pap染色劑
    • 傳統的非Pap染色劑
    • 圖像分析
    • 流式細胞技術
    • 免疫組織化學、原位雜合反應
    • 循環腫瘤細胞
  • 主要產品、價格
  • 全球銷售額:各檢驗類型
  • 全球實施數:各檢驗類型
  • 價格趨勢
  • 實施數趨勢

第11章 企業簡介、實施數分析

附錄:企業名錄

圖表清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: KLI5440452

Clinical laboratory medicine plays an integral role in healthcare and disease management, as it estimated that approximately 80% of physician's diagnoses are a result of laboratory tests. In addition to disease diagnosis, clinical lab testing is also performed to evaluate disease progression, monitor drug treatment and conditions, and determine individual therapy.

The global market for in vitro diagnostics (IVD) and clinical lab tests is strong, with a plethora of new products and rising procedure volumes through 2017. IVD Procedure Volumes and Pricing Analysis examines the global procedure volumes for IVD and laboratory tests. It covers only commercialized tests, specifically excluding those that are developmental or used primarily for research purposes. The report presents total global sales in 2014 of equipment, reagents and other products related to IVD and clinical laboratory tests.

Basic sales estimates for each major market segment represent global revenues and are expressed in current dollars. Segments covered include:

  • Point-of-Care (OTC Total, Glucose, Pregnancy/ Ovulation, Other, Professional Total, Glucose, Infectious Disease, Critical Care, Other)
  • Core lab (General Chemistries, Blood Gas Analyzers, Urinalysis, Immunoassays Infectious Disease, Cardiac Markers, Diabetes/HbA1c, Autoimmune)
  • Molecular (Infectious Disease [inc. molecular tests for HIV, Hepatitis, STDs, HAI, Respiratory, Other], Oncology, Inherited Disease, Other)
  • Hematology
  • Coagulation (PT, PTT)
  • Microbiology (Automated Panels, Manual Panels, Blood Culture, Chromogenic Media)
  • Blood Banking
  • Histology/Cytology (Pap, Non-Pap, Image Cytometry, Flow Cytometry, ISH, IHC, CTCs)

Pricing trend analysis is provided for each category. For each test type, estimates are provided for the historic 2014 period and forecasts are provided through 2019. Price estimates are offered for leading products, systems and equipment; these represent average list prices but do not take into account variations between countries, discounts or rebates and other fluctuations. Wherever possible, an attempt is made to present unit prices so that procedure volumes and trends may be more easily understood.

Trends that are contributing to strong and rising utilization of IVD and clinical lab tests are discussed. These include:

  • aging of the global population
  • high and rising incidence of disease
  • ongoing technology development and introduction of labor-saving systems

Diagnostic laboratory technology has changed dramatically in the past few years, due to the publication of the human genome project and advances in functional genomics, bioinformatics, automation, miniaturization and microelectronics as well as rapid development and proliferation of novel telecommunications technologies. IVD Procedure Volumes and Pricing Analysis is a unique business planning tool that tells readers which companies are performing what share of IVD procedures in this rapidly changing market. The following IVD leaders are profiled and their procedure volumes are analyzed in this report:

  • Abbott Laboratories
  • ALERE
  • Arkray
  • Beckman Coulter, Inc./Danaher
  • Becton, Dickinson & Co.
  • bioMerieux, Inc.
  • Bio-RAD Laboratories, Inc.
  • Bio-Reference Laboratories
  • Clarient, Inc./GE Healthcare
  • Danaher Corp.
  • DaVita, Inc.
  • Genoptix, Inc./Novartis
  • Gen-Probe, Inc.
  • Hologic, Inc.
  • Horiba Medical
  • Instrumentation Laboratory
  • Laboratory Corporation of America
  • Myriad Genetics
  • Ortho Clinical Diagnostics
  • Qiagen
  • Quest Diagnostics
  • Radiometer A/S
  • Roche
  • Siemens
  • Spectra Laboratories
  • Sysmex Corp.
  • Thermo Fisher Scientific

Historical information for this report was gathered from a wide variety of published sources including company reports and filings, government documents, legal filings, trade journals, newspapers and business press, analysts' reports and other sources. Interviews with company representatives and other experts were conducted to capture the perspectives from industry participants' point of view and assess trends, and form the basis of the forecasting and competitive analysis.

Table of Contents

ONE: EXECUTIVE SUMMARY

  • The Global In Vitro Diagnostics (IVD) and Laboratory Tests Market
    • Scope and Methodology
    • Size and Growth of the Market
    • Sales
    • Procedure Fees
    • Unit Test Prices
    • Procedure Volume
    • Market Trends

TWO: INTRODUCTION

  • Types of Tests
  • Venues for Test Usage
    • Hospitals
    • Physicians
    • Independent Clinical Laboratories
  • Population and Disease Demographics
    • World Population
    • Life Expectancy
    • Disease Incidence and Prevalence
    • Cancer
    • Diabetes
    • Obesity
    • Allergy and Asthma
    • Antimicrobial Drug Resistance
  • Regional Market Characteristics and Trends
    • United States
    • Europe
    • Japan
    • BRIC Nations
    • Brazil
    • Russia
    • India
    • China
    • Other Countries

THREE: POINT-OF-CARE TESTS

  • Overview
  • Types of Tests
    • OTC Tests
    • Glucose Tests
    • Pregnancy/Ovulation Tests
    • Professional Tests
    • Glucose Tests
    • Tests for Infectious Disease
    • Critical Care Tests
    • Other Tests
  • Leading Products and Prices
  • Global Sales by Test Type
  • Global Procedure Volume by Test Type
  • Pricing Trends
  • Procedure Volume Trends

FOUR: CORE LABORATORY TESTS

  • Overview
  • Types of Tests
    • Clinical Chemistries
    • General Chemistries
    • Blood Gas Analysis
    • Urinalysis
    • Immunoassays
    • Infectious Diseases
    • Cardiac Markers
    • Tumor Markers
    • Diabetes
    • Autoimmune Diseases
    • Other
  • Leading Products and Prices
  • Global Sales by Test Type
  • Global Procedure Volume by Test Type
  • Pricing Trends
  • Procedure Volume Trends

FIVE: MOLECULAR ASSAYS

  • Overview
  • Types of Tests
    • Infectious Disease
    • Oncology
    • Inherited Disease
    • Other
  • Leading Products and Prices
  • Global Sales by Test Type
  • Global Procedure Volume by Test Type
  • Pricing Trends
  • Procedure Volume Trends

SIX: HEMATOLOGY

  • Overview
  • Types of Tests
  • Leading Products and Prices
  • Global Sales
  • Global Procedure Volume
  • Pricing Trends
  • Procedure Volume Trends

SEVEN: COAGULATION

  • Overview
  • Types of Tests
    • Prothrombin Time Testing (PT)
    • Activated Thromboplastin Time (PTT)
  • Leading Products and Prices
  • Global Sales
  • Global Procedure Volume by Test Type
  • Pricing Trends
  • Procedure Volume Trends

EIGHT: MICROBIOLOGY

  • Overview
  • Types of Tests
    • Automated Panels and Reagents
    • Manual Panels and Reagents
    • Blood Culture
    • Chromogenic Media
  • Leading Products and Prices
  • Global Sales by Test Type
  • Global Procedure Volume by Test Type
  • Pricing Trends
  • Procedure Volume Trends

NINE: TESTS USED IN BLOOD BANKING

  • Overview
  • Types of Tests
  • Leading Products and Prices
  • Global Sales
  • Global Procedure Volume
  • Pricing Trends
  • Procedure Volume Trends

TEN: HISTOLOGY AND CYTOLOGY

  • Overview
  • Types of Tests
    • Pap Stains
    • Traditional Non-Pap Stains
    • Image Cytometry
    • Flow Cytometry
    • Immunohistochemistry and In Situ Hybridization
    • Circulating Tumor Cells
  • Leading Products and Prices
  • Global Sales by Test Type
  • Global Procedure Volume by Test Type
  • Pricing Trends
  • Procedure Volume Trends

ELEVEN: PROFILES OF KEY PLAYERS

  • Introduction
  • Abbott Laboratories
    • Overview
    • IVD/Lab Test Market Participation
    • Procedure Volume Share
    • Financial Snapshot
  • ALERE
    • Overview
    • Reproduction without prior written permission, in any media now in
    • existence or hereafter developed, in whole or in any part, is strictly prohibited
    • IVD/Lab Test Market Participation
    • Procedure Volume Share
    • Financial Snapshot
  • Arkray
    • Overview
    • IVD/Lab Test Market Participation
    • Procedure Volume Share
    • Financial Snapshot
  • Beckman Coulter, Inc./Danaher
    • Overview
    • IVD/Lab Test Market Participation
    • Procedure Volume Share
    • Financial Snapshot
  • Becton, Dickinson & Co.
    • Overview
    • IVD/Lab Test Market Participation
    • Procedure Volume Share
    • Financial Snapshot
  • bioMerieux, Inc.
    • Overview
    • IVD/Lab Test Market Participation
    • Procedure Volume Share
    • Financial Snapshot
  • Bio-RAD Laboratories, Inc.
    • Overview
    • IVD/Lab Test Market Participation
    • Procedure Volume Share
    • Financial Snapshot
  • Bio-Reference Laboratories
    • Overview
    • IVD/Lab Test Market Participation
    • Procedure Volume Share
    • Financial Snapshot
  • Clarient, Inc./GE Healthcare
    • Overview
    • IVD/Lab Test Market Participation
    • Procedure Volume Share
    • Financial Snapshot
  • Danaher Corp.
    • Overview
    • IVD/Lab Test Market Participation
    • Procedure Volume Share
    • Financial Snapshot
  • DaVita, Inc.
    • Overview
    • IVD/Lab Test Market Participation
    • Procedure Volume Share
    • Financial Snapshot
  • Genoptix, Inc./Novartis
    • Overview
    • IVD/Lab Test Market Participation
    • Procedure Volume Share
    • Financial Snapshot
  • Gen-Probe, Inc.
    • Overview
  • IVD/Lab Test Market Participation
    • Procedure Volume Share
    • Financial Snapshot
  • Hologic, Inc.
    • Overview
    • IVD/Lab Test Market Participation
    • Procedure Volume Share
    • Financial Snapshot
  • Horiba Medical
    • Overview
    • IVD/Lab Test Market Participation
    • Procedure Volume Share
    • Financial Snapshot
  • Instrumentation Laboratory
    • Overview
    • IVD/Lab Test Market Participation
    • Procedure Volume Share
    • Financial Snapshot
  • Laboratory Corporation of America
    • Overview
    • IVD/Lab Test Market Participation
    • Procedure Volume Share
    • Financial Snapshot
  • Myriad Genetics
    • Overview
    • IVD/Lab Test Market Participation
    • Procedure Volume Share
    • Financial Snapshot
  • Ortho Clinical Diagnostics
    • Overview
    • IVD/Lab Test Market Participation
    • Procedure Volume Share
    • Financial Snapshot
  • Qiagen
    • Overview
    • IVD/Lab Test Market Participation
    • Procedure Volume Share
    • Financial Snapshot
  • Quest Diagnostics
    • Overview
    • IVD/Lab Test Market Participation
    • Procedure Volume Share
    • Financial Snapshot
  • Radiometer A/S
    • Overview
    • IVD/Lab Test Market Participation
    • Procedure Volume Share
    • Financial Snapshot
  • Roche
    • Overview
    • IVD/Lab Test Market Participation
    • Procedure Volume Share
    • Financial Snapshot
  • Siemens
    • Overview
    • IVD/Lab Test Market Participation
    • Procedure Volume Share
    • Financial Snapshot
  • Spectra Laboratories
    • Overview
    • IVD/Lab Test Market Participation
    • Procedure Volume Share
    • Financial Snapshot
  • Sysmex Corp.
    • Overview
    • IVD/Lab Test Market Participation
    • Procedure Volume Share
    • Financial Snapshot
  • Thermo Fisher Scientific
    • Overview
    • IVD/Lab Test Market Participation
    • Procedure Volume Share
    • Financial Snapshot

APPENDIX: COMPANY DIRECTORY

LIST OF EXHIBITS

ONE: EXECUTIVE SUMMARY

  • Table 1-1: Global IVD and Clinical Lab Sales by Market Segment in $Million,2014 - 2019 (POC [Professional], Core lab, Molecular, Hematology, Coagulation,Microbiology, Blood Banking, Histology/Cytology, Total)
  • Table 1-2: Global IVD Sales and Clinical Lab Sales by Market Segment in $Million, 2014 -2019 (POC [Professional], Core lab, Molecular, Hematology, Coagulation, Microbiology,Blood Banking, Histology/Cytology, Total)
  • Table 1-3: Global IVD and Clinical Lab Unit Test Prices by Market Segment in $, 2014 -2019 (POC [Professional], Core lab, Molecular, Hematology, Coagulation,Microbiology, Blood Banking, Histology/Cytology, Total)
  • Table 1-4: Global IVD and Clinical Lab Procedure Volumes by Market Segment in$Million, 2014 - 2019 (POC [Professional], Core lab, Molecular, Hematology,Coagulation, Microbiology, Blood Banking, Histology/Cytology, Total)

TWO: INTRODUCTION

  • Table 2-1: Types of IVD and Clinical Laboratory Tests, 2015
  • Table 2-2: CLIA-Registered Laboratories by Type of Facility, 2012 (Ambulance,Ambulatory Surgery Center, Ancillary Test Site, Assisted Living Facility, Blood Bank,Community Clinic, Comprehensive Outpatient Rehab, End Stage Renal Dialysis,Federally Qualified Health Center, Health Fair, Health Maintenance Organization[HMO], Home Health Agency, Hospice, Hospital, Independent Lab, Industrial Lab,Insurance-Affiliated Lab, Intermediate Care Facility for the Mentally Retarded, MobileLab, Pharmacy, Physician Office, Other Practitioner, Prison, Public Health Lab, RuralHealth Clinic, School/Student Health Service, Skilled Nursing/Nursing Facility, TissueBank/Repository, Other, Total)
  • Table 2-3: Global Population, 1980 - 2020
  • Table 2-4: U.S. Population, 1980 - 2020
  • Table 2-5: Selected Global Disease Statistics, January 2014 (Cardiac Diseases includinghypertension, Diabetes, Asthma, Cancer, Respiratory Infections, Chlamydia,Gonorrhea, Malaria, HIV, Maternal Conditions, Syphilis, TB)
  • Exhibit 2-1: Global IVD and Clinical Lab Market, 2014 (Brazil, Russia, India, China,Japan, Eastern Europe, Western Europe, U.S., Other)

THREE: POINT-OF-CARE TESTS

  • Table 3-1: Selected POC Tests and Prices, 2015 (OTC: Glucose, Pregnancy/ Ovulation;
  • Professional: Glucose, Infectious Disease, Critical Care, Other)
  • Table 3-2: Global POC Test Sales by Test Type in $Million, 2014 - 2019 (OTC Total,Glucose, Pregnancy/ Ovulation, Other, Professional Total, Glucose, Infectious Disease,Critical Care, Other, Total POC)
  • Exhibit 3-1: Global POC Test Sales by Test Type in $Million, 2014 - 2019
  • Table 3-3: Global POC Test Procedure Volume by Test Type in Millions, 2014 - 2019(OTC Total, Glucose, Pregnancy/ Ovulation, Other, Professional Total, Glucose,Infectious Disease, Critical Care, Other, Total POC)
  • Exhibit 3-2: Global POC Test Procedure Volume by Test Type in Millions, 2014 - 2019

FOUR: CORE LABORATORY TESTS

  • Table 4-1: Selected Core Lab Tests and Prices, 2015 (Clinical Chemistries: GeneralChemistries, Blood Gas Analysis, Urinalysis; Immunoassays: Multipurpose)
  • Table 4-2: Global Core Lab Test Sales by Test Type in $Million, 2014 - 2019 (ClinicalChemistries Total, General Chemistries, Blood Gas Analyzers, Urinalysis,Immunoassays Total, Infectious Disease, Cardiac Markers, Tumor Markers,Diabetes/HbA1c, Autoimmune, Other, Total Core Lab)
  • Exhibit 4-1: Global Core Lab Test Sales by Test Type in $Million, 2014 - 2019
  • Table 4-3: Global Core Lab Test Procedure Volume by Test Type in Millions,2014 - 2019 (Clinical Chemistries Total, General Chemistries, Blood Gas Analyzers,Urinalysis, Immunoassays Total, Infectious Disease, Cardiac Markers, TumorMarkers, Diabetes/HbA1c, Autoimmune, Other, Total Core Lab)
  • Exhibit 4-2: Global Core Lab Test Procedure Volume by Test Type in Millions,2014 - 2019

FIVE: MOLECULAR ASSAYS

  • Table 5-1: Selected Molecular Assay Test Services and Prices, 2015 (Infectious Disease,Oncology, Inherited Disease, Other)
  • Table 5-2: Global Molecular Assay Sales by Test Type in $Million, 2014 - 2019 (InfectiousDisease, Oncology, Inherited Disease, Other, Total Molecular Assays)
  • Exhibit 5-1: Global Molecular Assay Sales by Test Type in $Million, 2014 - 2019 (InfectiousDisease, Oncology, Inherited Disease, Other)
  • Table 5-3: Global Molecular Assay Procedure Volume by Test Type in Millions, 2014 -2019 (Infectious Disease, Oncology, Inherited Disease, Other, Total MolecularAssays)
  • Exhibit 5-2: Global Molecular Assay Procedure Volume by Test Type in Millions, 2014 -2019 (Infectious Disease, Oncology, Inherited Disease, Other)

SIX: HEMATOLOGY

  • Table 6-1: Selected Hematology Analyzers and Prices, 2015
  • Table 6-2: Global Hematology Analyzer Sales in $Million, 2014 - 2019
  • Exhibit 6-1: Global Hematology Analyzer Sales in $Million, 2014 - 2019
  • Table 6-3: Global Lab-Based Hematology Test Procedure Volume in Millions, 2014 - 201987
  • Exhibit 6-2: Global Lab-Based Hematology Test Procedure Volume in Millions,2014 - 2019

SEVEN: COAGULATION

  • Table 7-1: Selected Coagulation Analyzers and Prices, 2015
  • Table 7-2: Global Coagulation Analyzer Sales in $Million, 2014 - 2019
  • Exhibit 7-1: Global Coagulation Analyzer Sales in $Million, 2014 - 2019
  • Table 7-3: Global Lab-Based Coagulation Test Procedure Volume by Test Type inMillions, 2012 - 2017 (PT, PTT, Total Coagulation)
  • Exhibit 7-2: Global Lab-Based Coagulation Test Procedure Volume by Test Type inMillions, 2014 - 2019

EIGHT: MICROBIOLOGY

  • Table 8-1: Selected Lab-Based ID/AST Microbiology Instruments and Prices, 2015(Automated Panels and Reagents, Manual Panels and Reagents, Blood CultureSystems, Chromogenic Media)
  • Table 8-2: Global Lab-Based ID/AST Microbiology Instrument Sales by Test Type inMillions, 2014 - 2019 (Automated Panels and Reagents, Manual Panels and Reagents,Blood Culture, Chromogenic Media, Total Microbiology)
  • Exhibit 8-1: Global Lab-Based ID/AST Microbiology Instrument Sales by Test Type inMillions, 2014 - 2019 (Automated Panels and Reagents, Manual Panels and Reagents,Blood Culture, Chromogenic Media)
  • Table 8-3: Global Lab-Based ID/AST Microbiology Procedure Volume by Test Type inMillions, 2014 - 2019 (Automated Panels and Reagents, Manual Panels and Reagents,Blood Culture, Chromogenic Media, Total Microbiology)
  • Exhibit 8-2: Global Lab-Based ID/AST Microbiology Procedure Volume by Test Type inMillions, 2014 - 2019 (Automated Panels and Reagents, Manual Panels and Reagents,Blood Culture, Chromogenic Media)

NINE: TESTS USED IN BLOOD BANKING

  • Table 9-1: Selected Blood Grouping Products and Prices, 2015
  • Table 9-2: Global Blood Grouping Product Sales in $Million, 2014 - 2019
  • Exhibit 9-1: Global Blood Grouping Product Sales in $Million, 2014 - 2019
  • Table 9-3: Global Blood Grouping Procedure Volume in $Million, 2014 - 2019
  • Exhibit 9-2: Global Blood Grouping Procedure Volume in $Million, 2014 - 2019

TEN: HISTOLOGY AND CYTOLOGY

  • Table 10-1: Selected Histology/Cytology Products and Prices, 2015 (Pap Stain, Non-PapStains, Image Cytometry, Flow Cytometry, ISH, IHC, CTCs)
  • Table 10-2: Global Histology/Cytology Sales by Test Type in $Millions, 2014 - 2019 (Pap,Non-Pap Stains, Image Cytometry, Flow Cytometry, In Situ Hybridization [ISH],Immunohistochemistry [IHC], Circulating Tumor Cells [CTCs], TotalHistology/Cytology)
  • Exhibit 10-1: Global Histology/Cytology Sales by Test Type in $Millions, 2014 - 2019(Pap, Non-Pap Stains, Image Cytometry, Flow Cytometry, In Situ Hybridization,Immunohistochemistry, CTCs)
  • Table 10-3: Global Histology/Cytology Procedure Volume by Test Type in Millions,2014 - 2019 (Pap, Non-Pap Stains, Image Cytometry, Flow Cytometry, In SituHybridization [ISH], Immunohistochemistry [IHC], Circulating Tumor Cells [CTCs],Total Histology/Cytology)
  • Exhibit 10-2: Global Histology/Cytology Procedure Volume by Test Type in Millions,2014 - 2019 (Pap, Non-Pap Stains, Image Cytometry, Flow Cytometry, In SituHybridization, Immunohistochemistry, CTCs)

ELEVEN: PROFILES OF KEY PLAYERS

  • Table 11-1: Global Sales and Procedure Volumes of the Leading Manufacturers of IVDand Clinical Lab Products and Equipment, 2014
  • Table 11-2: Global Procedure Fees of the Leading Clinical Laboratories, 2014
  • Table 11-3: Abbott Laboratories Estimated Global IVD and Clinical Lab ProcedureVolume by Market Segment in Millions, 2014 (POC including Glucose, Core Lab,Molecular Assays, Hematology, Histology/Cytology, Total)
  • Table 11-4: Abbott Laboratories Estimated Global IVD and Clinical Lab Sales byMarket Segment in $Millions, 2014 (POC including Glucose, Core Lab, MolecularAssays, Hematology, Histology/Cytology, Total)
  • Table 11-5: Alere Estimated Global IVD and Clinical Lab Procedure Volume by MarketSegment in Millions, 2014 (POC including Glucose, Total)
  • Table 11-6: Alere Estimated Global IVD and Clinical Lab Sales by Market Segment in$Millions, 2014 (POC including Glucose, Total)
  • Table 11-7: Arkray Estimated Global IVD and Clinical Lab Procedure Volume byMarket Segment in Millions, 2014 (POC including Glucose, Core Lab, Total)
  • Table 11-8: Arkray Estimated Global IVD and Clinical Lab Sales by Market Segment in$Millions, 2014 (POC including Glucose, Core Lab, Total)
  • Table 11-9: Beckman Coulter Estimated Global IVD and Clinical Lab ProcedureVolume by Market Segment in Millions, 2014 (Core Lab, Molecular Assays,Hematology, Coagulation, Histology/Cytology, Total)
  • Table 11-10 : Beckman Coulter Estimated Global IVD and Clinical Lab Sales by MarketSegment in $Millions, 2014 (Core Lab, Molecular Assays, Hematology, Coagulation,Histology/Cytology, Total)
  • Table 11-11: Becton Dickinson Estimated Global IVD and Clinical Lab ProcedureVolume by Market Segment in Millions, 2014 (Core Lab, Molecular Assays,Microbiology, Histology/Cytology, Total)
  • Table 11-12: Becton Dickinson Estimated Global IVD and Clinical Lab Sales by MarketSegment in $Millions, 2014 (Core Lab, Molecular Assays, Microbiology,Histology/Cytology, Total)
  • Table 11-13: bioMerieux Estimated Global IVD and Clinical Lab Procedure Volume byMarket Segment in Millions, 2014 (Core Lab, Molecular Assays, Microbiology,Total)
  • Table 11-14: bioMerieux Estimated Global IVD and Clinical Lab Sales by MarketSegment in $Millions, 2014 (Core Lab, Molecular Assays, Microbiology, Total)
  • Table 11-15: Bio-Rad Estimated Global IVD and Clinical Lab Procedure Volume byMarket Segment in Millions, 2014 (Core Lab, Blood Banking, Total)
  • Table 11-16: Bio-Rad Estimated Global IVD and Clinical Lab Sales by Market Segmentin $Millions, 2014 (Core Lab, Blood Banking, Total)
  • Table 11-17: Bio-Reference Laboratories Estimated Global IVD and Clinical LabProcedure Volume by Market Segment in Millions, 2014 (Core Lab, MolecularAssays, Hematology, Microbiology, Total)
  • Table 11-18: Bio-Reference Laboratories Estimated Global IVD and Clinical LabProcedure Fees by Market Segment in $Millions, 2014 (Core Lab, Molecular Assays,Hematology, Microbiology, Total)
  • Table 11-19: Clarient Estimated Global IVD and Clinical Lab Procedure Volume byMarket Segment in Millions, 2014 (Core Lab, Molecular Assays, Total)
  • Table 11-20: Clarient Estimated Global IVD and Clinical Lab Procedure Fees byMarket Segment in $Millions, 2014 (Core Lab, Molecular Assays, Total)
  • Table 11-21: Danaher Estimated Global IVD and Clinical Lab Procedure Volume byMarket Segment in Millions, 2014 (Molecular Assays, Microbiology,Histology/Cytology, Total)
  • Table 11-22: Danaher Estimated Global IVD and Clinical Lab Sales by Market Segmentin $Millions, 2014 (Molecular Assays, Microbiology, Histology/Cytology, Total)
  • Table 11-23: DaVita Estimated Global IVD and Clinical Lab Procedure Volume byMarket Segment in Millions, 2014 (Core Lab, Hematology, Microbiology, Total)
  • Table 11-24: DaVita Estimated Global IVD and Clinical Lab Procedure Fees by MarketSegment in $Millions, 2014 (Core Lab, Hematology, Microbiology, Total)
  • Table 11-25: Genoptix Estimated Global IVD and Clinical Lab Procedure Volume byMarket Segment in Millions, 2014 (Core Lab, Molecular Assays, Histology/Cytology,Total)
  • Table 11-26: Genoptix Estimated Global IVD and Clinical Lab Procedure Fees by MarketSegment in $Millions, 2014 (Core Lab, Molecular Assays, Histology/Cytology,Total)
  • Table 11-27: Gen-Probe Estimated Global IVD and Clinical Lab Procedure Volume byMarket Segment in Millions, 2014 (Core Lab, Molecular Assays, Total)
  • Table 11-28: Gen-Probe Estimated Global IVD and Clinical Lab Sales by MarketSegment in $Millions, 2014 (Core Lab, Molecular Assays, Total)
  • Table 11-29: Hologic Estimated Global IVD and Clinical Lab Procedure Volume byMarket Segment in Millions, 2014 (Molecular Assays, Histology/Cytology, Total)
  • Table 11-30: Hologic Estimated Global IVD and Clinical Lab Sales by Market Segmentin $Millions, 2014 (Molecular Assays, Histology/Cytology, Total)
  • Table 11-31: Horiba Estimated Global IVD and Clinical Lab Procedure Volume byMarket Segment in Millions, 2014 (POC including Glucose, Core Lab, Hematology,Total)
  • Table 11-32: Horiba Estimated Global IVD and Clinical Lab Sales by Market Segmentin $Millions, 2014 (POC including Glucose, Core Lab, Hematology, Total)
  • Table 11-33: Instrumentation Laboratory Estimated Global IVD and Clinical LabProcedure Volume by Market Segment in Millions, 2014 (POC including Glucose,Coagulation, Total)
  • Table 11-34: Instrumentation Laboratory Estimated Global IVD and Clinical Lab Salesby Market Segment in $Millions, 2014 (POC including Glucose, Coagulation, Total)
  • Table 11-35: Labcorp Estimated Global IVD and Clinical Lab Procedure Volume byMarket Segment in Millions, 2014 (POC including Glucose, Core Lab, MolecularAssays, Hematology, Coagulation, Microbiology, Histology/Cytology, Total)
  • Table 11-36: Labcorp Estimated Global IVD and Clinical Lab Procedure Fees by MarketSegment in $Millions, 2014 (POC including Glucose, Core Lab, Molecular Assays,Hematology, Coagulation, Microbiology, Histology/Cytology, Total)
  • Table 11-37: Myriad Genetics Estimated Global IVD and Clinical Lab Procedure Volumeby Market Segment in Millions, 2014 (Molecular Assays, Total)
  • Table 11-38: Myriad Genetics Estimated Global IVD and Clinical Lab Procedure Fees byMarket Segment in $Millions, 2014 (Molecular Assays, Total)
  • Table 11-39: Ortho Clinical Diagnostics Estimated Global IVD and Clinical LabProcedure Volume by Market Segment in Millions, 2014 (Core Lab, Blood Banking,Total)
  • Table 11-40: Ortho Clinical Diagnostics Estimated Global IVD and Clinical Lab Sales byMarket Segment in $Millions, 2014 (Core Lab, Blood Banking, Total)
  • Table 11-41: Qiagen Estimated Global IVD and Clinical Lab Procedure Volume byMarket Segment in Millions, 2014 (Molecular Assay, Histology/Cytology, Total)
  • Table 11-42: Qiagen Estimated Global IVD and Clinical Lab Sales by Market Segmentin $Millions, 2014 (Molecular Assay, Histology/Cytology, Total)
  • Table 11-43: Quest Diagnostics Estimated Global IVD and Clinical Lab ProcedureVolume by Market Segment in Millions, 2014 (POC including Glucose, Core Lab,
  • Molecular Assays, Hematology, Coagulation, Microbiology, Histology/Cytology,Total)
  • Table 11-44: Quest Diagnostics Estimated Global IVD and Clinical Lab Procedure Feesby Market Segment in $Millions, 2014 (POC including Glucose, Core Lab, MolecularAssays, Hematology, Coagulation, Microbiology, Histology/Cytology, Total)
  • Table 11-45: Radiometer A/S Estimated Global IVD and Clinical Lab Procedure Volumeby Market Segment in Millions, 2014 (POC including Glucose, Core Lab, Total)
  • Table 11-46: Radiometer A/S Estimated Global IVD and Clinical Lab Sales by MarketSegment in $Millions, 2014 (POC including Glucose, Core Lab, Total)
  • Table 11-47: Roche Estimated Global IVD and Clinical Lab Procedure Volume byMarket Segment in Millions, 2014 (POC including Glucose, Core Lab, MolecularAssays, Histology/Cytology, Total)
  • Table 11-48: Roche Estimated Global IVD and Clinical Lab Sales by Market Segment in$Millions, 2014 (POC including Glucose, Core Lab, Molecular Assays,Histology/Cytology, Total)
  • Table 11-49: Siemens Estimated Global IVD and Clinical Lab Procedure Volume byMarket Segment in Millions, 2014 (POC including Glucose, Core Lab, MolecularAssays, Hematology, Coagulation, Microbiology, Total)
  • Table 11-50: Roche Estimated Global IVD and Clinical Lab Sales by Market Segment in$Millions, 2014 (POC including Glucose, Core Lab, Molecular Assays, Hematology,Coagulation, Microbiology, Total)
  • Table 11-51: Spectra Laboratories Estimated Global IVD and Clinical Lab ProcedureVolume by Market Segment in Millions, 2014 (POC including Glucose, Core Lab,Hematology, Microbiology, Total)
  • Table 11-52: Spectra Laboratories Estimated Global IVD and Clinical Lab ProcedureFees by Market Segment in $Millions, 2014 (POC including Glucose, Core Lab,Hematology, Microbiology, Total)
  • Table 11-53: Sysmex Estimated Global IVD and Clinical Lab Procedure Volume byMarket Segment in Millions, 2014 (Core Lab, Hematology, Coagulation, Total)
  • Table 11-54: Sysmex Estimated Global IVD and Clinical Lab Sales by Market Segmentin $Millions, 2014 (Core Lab, Hematology, Coagulation, Total)
  • Table 11-55: Thermo Fisher Scientific Estimated Global IVD and Clinical Lab ProcedureVolume by Market Segment in Millions, 2014 (Core Lab, Microbiology,Histology/Cytology, Total)
  • Table 11-56: Thermo Fisher Scientific Estimated Global IVD and Clinical Lab Sales byMarket Segment in $Millions, 2014 (Core Lab, Microbiology, Histology/Cytology,Total)
Back to Top